#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17124	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2181	781.3	0	.	n	.	0	A69G	SNP	69	69	A	390	390	G	1042	G,A	969,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17124	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2181	781.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1771	1771	T	981	T,C	916,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17124	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2181	781.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1505	1505	C	964	C	904	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3593	863.1	0	.	n	.	0	T695C	SNP	695	695	T	1004	1004	C	913	C,T	860,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3593	863.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2280	2280	C	984	C,G,T	909,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3593	863.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2354	2354	A	1021	A	964	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3593	863.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2906	2906	C	963	C,A,T	916,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	10	blaTEM	861	237	99.58	blaTEM.l15.c4.ctg.1	237	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2502	folP	855	855	100.0	folP.l6.c17.ctg.1	1532	162.4	1	SNP	p	R229S	1	.	.	685	687	AGC	967	969	AGC	261;264;261	A;G;C	244;248;244	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6580	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3257	200.9	1	SNP	p	S91F	1	.	.	271	273	TTC	523	525	TTC	210;211;214	T;T;C	194;196;200	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6580	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3257	200.9	1	SNP	p	G95N	0	.	.	283	285	GGC	535	537	GGC	216;215;213	G;G;C	204;200;200	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6580	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3257	200.9	1	SNP	p	D95G	1	.	.	283	285	GGC	535	537	GGC	216;215;213	G;G;C	204;200;200	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1918	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1286	148.2	0	.	p	.	0	D79N	NONSYN	235	237	GAT	547	549	AAT	233;231;230	A;A;T	220;218;217	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1918	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1286	148.2	1	SNP	p	G45D	0	.	.	133	135	GGC	445	447	GGC	233;232;233	G;G;C	211;210;212	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	990	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1100	89.9	0	.	n	.	0	A197.	DEL	197	197	A	550	550	A	212	A	196	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	0	.	p	.	0	E91G	NONSYN	271	273	GAG	562	564	GGG	210;208;208	G;G;G	196;196;196	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	1	SNP	p	D86N	0	.	.	256	258	GAC	547	549	GAC	212;211;216	G;A;C	199;195;202	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	1	SNP	p	S87I	0	.	.	259	261	AGT	550	552	AGT	216;213;214	A;G;T	203;199;202	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	1	SNP	p	S87W	0	.	.	259	261	AGT	550	552	AGT	216;213;214	A;G;T	203;199;202	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	1	SNP	p	S87R	0	.	.	259	261	AGT	550	552	AGT	216;213;214	A;G;T	203;199;202	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5818	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2905	199.6	1	SNP	p	S88P	0	.	.	262	264	TCC	553	555	TCC	214;215;216	T;C;C	201;198;201	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5068	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2774	182.3	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1643	1645	CAC	210;210;214	C;A;C	202;195;201	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5068	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2774	182.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1592	1594	GGC	248;245;245	G;G,C;C,A	232;227,1;227,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1294	1296	GCA	254;257;263	G,T;C;A	234,1;237;245	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1297	1299	ATC	260;264;267	A;T;C	248;247;248	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1309	1311	GTG	269;267;272	G;T;G	249;244;251	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1309	1311	GTG	269;267;272	G;T;G	249;244;251	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1813	1815	ACC	232;235;233	A,G;C;C	205,1;221;220	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1867	1869	ACG	229;231;232	A;C;G	186;193;188	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1867	1869	ACG	229;231;232	A;C;G	186;193;188	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1990	1992	GGC	225;222;220	G;G;C	214;208;205	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1999	2001	GGC	232;229;229	G;G;C	212;210;209	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4582	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2393	190.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2017	2019	CTG	216;217;216	C,G;T;G	156,8;153;163	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6684	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3129	213.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1585	1587	CCG	193;196;196	C;C;G	176;182;175	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2678	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1801	147.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	534	534	C	224	C	208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3426	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1732	197.3	1	SNP	p	G120K	1	.	.	358	360	AAG	704	706	AAG	280;278;278	A;A;G	264;262;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3426	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1732	197.3	1	SNP	p	A121N	1	.	.	361	363	AAC	707	709	AAC	279;280;280	A;A;C	259;260;259	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3426	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1732	197.3	1	SNP	p	N121D	0	.	.	361	363	AAC	707	709	AAC	279;280;280	A;A;C	259;260;259	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12354	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4858	253.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1958	1960	CAT	250;252;250	C;A;T	238;240;236	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1380	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1114	123.2	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	276;276;271	A;T;G	262;261;258	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
